A leading contract research organization (CRO) dedicated to ophthalmology, Iris Pharma helps clients around the world navigate every stage of the drug and medical device development process – including in vivo ocular efficacy studies, Good Laboratory Practice (GLP) preclinical studies, bioanalysis, clinical trials, and marketing surveys.
Iris Pharma has partnered with clients to bring more than 70 ocular drugs and medical devices to market in the past 34 years, and offers consulting services to help clients determine the best indication for molecules and products in development.
